Previous studies have shown that ADAR1-mediated RNA editing was elevated in breast cancer as compared with matched, normal breast tissue41,42 and compared with other types of cancers41, but the impact of BRCA1/2 mutations on the magnitude of A-to-I RNA editing in cancer remains unknown. This evidence concerns the gene BRCA1 and cancer.